Entry
Name
Lipid and atherosclerosis - Equus caballus (horse)
Description
Atherosclerosis is a chronic inflammatory disease marked by a narrowing of the arteries from lipid-rich plaques present within the walls of arterial blood vessels. It represents the root cause of the majority of cardiovascular diseases (CVDs) and their complications, including conditions such as coronary artery disease, myocardial infarction and stroke. An elevated level of low density lipoprotein (LDL) cholesterol constitutes a major risk factor for genesis of atherosclerosis. LDL can accumulate within the blood vessel wall and undergo modification by oxidation. Oxidized LDL (oxLDL) leads to endothelial dysfunction leading to expression of adhesion molecules and recruitment of monocyte in subendothelial space. The monocytes proliferate, differentiate into macrophages, and take up the lipoproteins, forming cholesterol-engorged "foam cells." With the time, the foam cells die, leaving a 'necrotic core' of crystalline cholesterol and cell debris. Smooth muscle cells proliferate and migrate into the region, laying down a protective cap over the lesion. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), which mediates the recognition and internalization of oxLDL, is involved in all of these events critical in the pathogenesis of atherosclerosis.
Class
Human Diseases; Cardiovascular disease
BRITE hierarchy
Pathway map
Ortholog table
Organism
Equus caballus (horse) [GN:
ecb ]
Gene
100062370 OLR1; oxidized low-density lipoprotein receptor 1 isoform X1 [KO:K08763 ]
102150569 ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330 ]
100051623 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
100058141 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
100051753 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
100052122 phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
100050227 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3 [KO:K02649 ]
100146348 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
100051363 POU2F1; POU domain, class 2, transcription factor 1 isoform X6 [KO:K09364 ]
100069713 POU2F2; POU domain, class 2, transcription factor 2 isoform X4 [KO:K09364 ]
100034049 CD40; tumor necrosis factor receptor superfamily member 5 precursor [KO:K03160 ]
100051699 AGER; advanced glycosylation end product-specific receptor isoform X1 [KO:K19722 ]
100061732 RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392 ]
100034011 STAT3; signal transducer and activator of transcription 3 [KO:K04692 ]
100067894 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X4 [KO:K02580 ]
100071639 FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390 ]
111769297 LOW QUALITY PROTEIN: heat shock 70 kDa protein 1-like [KO:K03283 ]
100630219 CD14; monocyte differentiation antigen CD14 precursor [KO:K04391 ]
100064503 TIRAP; toll/interleukin-1 receptor domain-containing adapter protein [KO:K05403 ]
100053940 MYD88; myeloid differentiation primary response protein MyD88 [KO:K04729 ]
100070300 TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform X1 [KO:K04403 ]
100060433 TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 isoform X1 [KO:K04404 ]
100051339 TANK; TRAF family member-associated NF-kappa-B activator isoform X4 [KO:K12650 ]
100051258 PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530 ]
100057737 VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730 ]
100069175 VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730 ]
100034121 CXCL1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) precursor [KO:K05505 ]
100056258 MIP-2BETA; uncharacterized protein LOC100056258 precursor [KO:K05505 ]
100073322 NLRP3; NACHT, LRR and PYD domains-containing protein 3 [KO:K12800 ]
111773414 ATF6; cyclic AMP-dependent transcription factor ATF-6 alpha [KO:K09054 ]
100054748 ERO1A; ERO1-like protein alpha isoform X1 [KO:K10950 ] [EC:1.8.4.-]
100052808 ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958 ]
100064138 CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X13 [KO:K04515 ] [EC:2.7.11.17 ]
100071654 CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
100072618 CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X6 [KO:K04515 ] [EC:2.7.11.17 ]
100146368 CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
100052709 EIF2S1; eukaryotic translation initiation factor 2 subunit 1 [KO:K03237 ]
100070334 ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374 ]
100054241 ABCA1; ATP-binding cassette sub-family A member 1 isoform X2 [KO:K05641 ]
100058103 ABCG1; ATP-binding cassette sub-family G member 1 isoform X1 [KO:K05679 ]
100066816 NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X2 [KO:K05638 ]
100063252 apoptosis-associated speck-like protein containing a CARD isoform X2 [KO:K12799 ]
100050907 VLDLR; very low-density lipoprotein receptor isoform X1 [KO:K20053 ]
100065378 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446 ]
100052657 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X4 [KO:K17332 ]
100053856 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333 ]
100057315 PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
100051558 PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
100051485 PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
100070545 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X3 [KO:K01116 ] [EC:3.1.4.11 ]
100064482 CALML6; LOW QUALITY PROTEIN: calmodulin-like protein 6 [KO:K02183 ]
100057357 PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
100067434 PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X4 [KO:K04348 ] [EC:3.1.3.16 ]
100072862 PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
100064377 TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721 ]
100057812 TNFRSF10B; tumor necrosis factor receptor superfamily member 10B isoform X1 [KO:K04722 ]
102149226 tumor necrosis factor receptor superfamily member 10A [KO:K04722 ]
102150834 tumor necrosis factor receptor superfamily member 1A isoform X1 [KO:K04722 ]
100059548 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158 ]
100052326 FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389 ]
Compound
C01245 D-myo-Inositol 1,4,5-trisphosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
C21011 [Protein]-N(epsilon)-(carboxymethyl)lysine
C21012 [Protein]-N(epsilon)-(carboxyethyl)lysine
Reference
Authors
Hopkins PN
Title
Molecular biology of atherosclerosis.
Journal
Reference
Authors
Weber C, Noels H
Title
Atherosclerosis: current pathogenesis and therapeutic options.
Journal
Reference
Authors
Tabas I, Garcia-Cardena G, Owens GK
Title
Recent insights into the cellular biology of atherosclerosis.
Journal
Reference
Authors
Tall AR, Yvan-Charvet L
Title
Cholesterol, inflammation and innate immunity.
Journal
Reference
Authors
Kattoor AJ, Goel A, Mehta JL
Title
LOX-1: Regulation, Signaling and Its Role in Atherosclerosis.
Journal
Reference
Authors
Mehta JL, Li D
Title
Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor.
Journal
Reference
Authors
Li D, Mehta JL
Title
Intracellular signaling of LOX-1 in endothelial cell apoptosis.
Journal
Reference
Authors
Lubrano V, Balzan S
Title
LOX-1 and ROS, inseparable factors in the process of endothelial damage.
Journal
Reference
Authors
Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P
Title
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.
Journal
Reference
Authors
Mitra S, Goyal T, Mehta JL
Title
Oxidized LDL, LOX-1 and atherosclerosis.
Journal
Reference
Authors
Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL
Title
Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis.
Journal
Reference
Authors
Ou HC, Song TY, Yeh YC, Huang CY, Yang SF, Chiu TH, Tsai KL, Chen KL, Wu YJ, Tsai CS, Chang LY, Kuo WW, Lee SD
Title
EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.
Journal
Reference
Authors
Chen XP, Zhang TT, Du GH
Title
Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
Journal
Reference
Authors
Mattaliano MD, Wooters J, Shih HH, Paulsen JE
Title
ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.
Journal
Reference
Authors
Salvador B, Arranz A, Francisco S, Cordoba L, Punzon C, Llamas MA, Fresno M
Title
Modulation of endothelial function by Toll like receptors.
Journal
Reference
Authors
Moore KJ, Sheedy FJ, Fisher EA
Title
Macrophages in atherosclerosis: a dynamic balance.
Journal
Reference
Authors
Butoi E, Gan AM, Manduteanu I
Title
Molecular and functional interactions among monocytes/macrophages and smooth muscle cells and their relevance for atherosclerosis.
Journal
Reference
Authors
Sheedy FJ, Moore KJ
Title
IL-1 signaling in atherosclerosis: sibling rivalry.
Journal
Reference
Authors
Moore KJ, Tabas I
Title
Macrophages in the pathogenesis of atherosclerosis.
Journal
Reference
Authors
Gui T, Shimokado A, Sun Y, Akasaka T, Muragaki Y
Title
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery.
Journal
Reference
Authors
Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL
Title
CD36 and macrophages in atherosclerosis.
Journal
Reference
Authors
Park YM, Febbraio M, Silverstein RL
Title
CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.
Journal
Reference
Authors
Park YM
Title
CD36, a scavenger receptor implicated in atherosclerosis.
Journal
Reference
Authors
Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, Tabas I
Title
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.
Journal
Reference
Authors
Nimgulkar C, Ghosh S, Sankar AB, Uday KP, Surekha MV, Madhusudhanachary P, Annapurna BR, Raghu P, Bharatraj DK
Title
Combination of spices and herbal extract restores macrophage foam cell migration and abrogates the athero-inflammatory signalling cascade of atherogenesis.
Journal
Reference
Authors
Canton J, Neculai D, Grinstein S
Title
Scavenger receptors in homeostasis and immunity.
Journal
Reference
Authors
Erridge C
Title
The roles of Toll-like receptors in atherosclerosis.
Journal
Reference
Authors
Seneviratne AN, Sivagurunathan B, Monaco C
Title
Toll-like receptors and macrophage activation in atherosclerosis.
Journal
Reference
Authors
Miller YI, Choi SH, Wiesner P, Fang L, Harkewicz R, Hartvigsen K, Boullier A, Gonen A, Diehl CJ, Que X, Montano E, Shaw PX, Tsimikas S, Binder CJ, Witztum JL
Title
Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.
Journal
Reference
Authors
Tabas I
Title
The role of endoplasmic reticulum stress in the progression of atherosclerosis.
Journal
Reference
Authors
Grootaert MOJ, Moulis M, Roth L, Martinet W, Vindis C, Bennett MR, De Meyer GRY
Title
Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis.
Journal
Reference
Authors
Lipskaia L, Pourci ML, Delomenie C, Combettes L, Goudouneche D, Paul JL, Capiod T, Lompre AM
Title
Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation.
Journal
Reference
Authors
Cervantes Gracia K, Llanas-Cornejo D, Husi H
Title
CVD and Oxidative Stress.
Journal
Reference
Authors
Hansson GK, Hermansson A
Title
The immune system in atherosclerosis.
Journal
Reference
Authors
Roy H, Bhardwaj S, Yla-Herttuala S
Title
Molecular genetics of atherosclerosis.
Journal
Reference
Authors
Lusis AJ, Fogelman AM, Fonarow GC
Title
Genetic basis of atherosclerosis: part I: new genes and pathways.
Journal
Reference
Authors
Lusis AJ, Mar R, Pajukanta P
Title
Genetics of atherosclerosis.
Journal
Related pathway
ecb04141 Protein processing in endoplasmic reticulum
ecb04620 Toll-like receptor signaling pathway
ecb04621 NOD-like receptor signaling pathway
ecb04670 Leukocyte transendothelial migration
ecb05418 Fluid shear stress and atherosclerosis
KO pathway
LinkDB
All DBs